Medical Research
(H410)
IRS Verified
DX Registered
990 on File
FOUNDATION FIGHTING BLINDNESS INC
Financial strength (30%)
80/100
Reliability (20%)
76/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Mission Statement
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
Financial Overview — FY 2025
$36.6M
Total Revenue
$49.5M
Total Expenses
$83.9M
Net Assets
96
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
75.4%
Fundraising Efficiency
1489.8%
Operating Reserve
20.32x
Liability-to-Asset
24.4%
Revenue Diversification
84.8%
Executive Compensation
$2.4M
Compared with Peers
FY 2025
Compared with 46 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
75.4% | 81.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.4% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
18.2% | 0.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1489.8% | 1489.8% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.3 mo | 18.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
24.4% | 22.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.8% | 84.5% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
2.6% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
2.7% | 5.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-35.3% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $36.6M | $49.5M | $83.9M | 75.4% | 96 |
| 2024 | $35.7M | $48.2M | $92.6M | 77.6% | 78 |
| 2023 | $30.4M | $51.3M | $100.2M | 80.7% | 67 |
| 2022 | $42.9M | $49.2M | N/A | — | 68 |
| 2021 | $29.8M | $40.7M | N/A | — | 67 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.